Dry Powder Insulin: Due diligence of a Licensing or Acquisition Deal

Dry Powder Insulin: Due diligence of a Licensing or Acquisition Deal

We represented a large Japanese company concerning the due diligence of a licensing or acquisition deal involving dry powder insulin technology (hereafter “the Technology”) of a large U.S. based company. We reviewed an extensive patent portfolio covering the Technology, including composition of matter, methods of use/treatment, delivery technology and devices. We performed a comprehensive review of each patent and their related file histories and conducted extensive prior art searches of the Technology. In addition, we met with the target’s leadership team and key personnel. We also worked with regulatory counsel to ascertain the potential path forward for FDA approval. At each stage of our project, we kept the client informed about progress and the budget.

Tags: , ,

Michael McGurk

Mike McGurk has more than 30 years of experience in virtually all aspects of patent law. Working with clients ranging from small start-ups to large Fortune 100 companies, he provides counsel in due diligence matters, global portfolio development and adversarial proceedings, including litigation, post-grant reviews, interferences and re-examinations. Mike works primarily with pharmaceutical, chemical, medical device and mechanical technology businesses. For at least the last fifteen (15) years, approximately 50-70% of Mike’s work has been focused in life sciences, including ANDA litigation support and pre-filing due diligence. Mike’s practice is informed by his background as a patent examiner in the chemical arts for the United States Patent and Trademark Office (USPTO), as a litigator for ten years, and as an expert in due diligence matters. He regularly provides strategic litigation counseling support to clients across the nation, and has handled numerous patent matters before the Patent Trial and Appeal Board of the USPTO. His extensive due diligence experience includes pre-litigation, acquisition, in-license, freedom-to-operate product and/or process clearance, design around, validity and patentability matters. Mike works with teams having the appropriate technical and legal abilities.